From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...

On-site monitoring is a significant expense for pharmaceutical and biotech sponsors, accounting for up to 30 percent of the cost of a clinical trial ... issuing an on-site visit, it’s a drastic ...

Hetlage, 65, has some hope in what could be a medical breakthrough. She is enrolled in a pioneering clinical trial that has implications far beyond her rare form of cancer. Through Memorial Cancer ...

Halving the number of times vital signs and neurological function are checked in low-risk patients after treatment for acute ischaemic stroke does not compromise care or recovery, according to new ...

Bringing new products to market in the era of outsourced clinical trials is reliant on the ability of sponsors and CROs to work together. The increasing globalisation of R&D has led to a rise in ...

Cat pooping with blood can be alarming. Understand the potential causes, symptoms, and treatment options to ensure your cat's health and well-being.

This Review presents a 10-step guide to critical appraisal that aims to assist clinicians to identify the most relevant high-quality studies available to guide their clinical practice.

Neurogene has introduced a new monitoring and treatment system for its adeno-associated virus (AAV) gene therapy after a Rett syndrome patient died during a clinical trial. Announced during the ...

Assessing clinical history and performing a thorough clinical breast examination are essential to managing risk and preventing a delayed diagnosis of breast cancer. CME/CE Workup of Abnormal ...

Prime Minister Modi issued a stern warning to Pakistan, emphasizing India's firm response to terror attacks following Operation Sindoor. External Affairs Minister ...

The RECONNECT Phase 2 clinical trial (NCT06342310) is a multicenter (38 clinical research sites in U.S.), randomized, double-blind, parallel-group, active dose-controlled clinical trial evaluating the ...

The Rasmussen Reports daily Presidential Tracking Poll for Tuesday shows that 52% of Likely U.S. Voters approve of President Trump’s job performance. forty-seven percent (47%) disapprove.